Compounds > 4-butyrolactone
Page last updated: 2024-08-18

4-butyrolactone and Osteoporosis

4-butyrolactone has been researched along with Osteoporosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, TT; Cui, J; Hua, YQ; Huang, TY; Li, MY; Lin, ZW; Yang, F1
Bai, L; Ma, Z1
Hsiao, HB; Lin, H; Lin, WC; Wu, JB1

Other Studies

3 other study(ies) available for 4-butyrolactone and Osteoporosis

ArticleYear
Ligustilide, a major bioactive component of Angelica sinensis, promotes bone formation via the GPR30/EGFR pathway.
    Scientific reports, 2019, 05-06, Volume: 9, Issue:1

    Topics: 4-Butyrolactone; Angelica sinensis; Animals; Apoptosis; Bone Density Conservation Agents; Cell Line; Disease Models, Animal; Embryo, Nonmammalian; Gene Expression Regulation; Green Fluorescent Proteins; Larva; Mesenchymal Stem Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteoblasts; Osteoporosis; Prednisolone; Primary Cell Culture; Proto-Oncogene Proteins c-bcl-2; Rats; Receptors, G-Protein-Coupled; Zebrafish; Zebrafish Proteins

2019
The anti-inflammatory effect of Z-Ligustilide in experimental ovariectomized osteopenic rats.
    Inflammation, 2012, Volume: 35, Issue:6

    Topics: 4-Butyrolactone; Aldehydes; Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Female; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; Neutrophils; NF-kappa B; Nitric Oxide Synthase Type II; Osteoporosis; Ovariectomy; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Up-Regulation

2012
Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013, Volume: 24, Issue:5

    Topics: 4-Butyrolactone; Animals; Bone Density Conservation Agents; Bone Resorption; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Mice; Mice, Inbred ICR; Monosaccharides; NF-kappa B; Osteoclasts; Osteoporosis; Ovariectomy; RANK Ligand; Rats; Rats, Wistar; X-Ray Microtomography

2013